SignatureFD
MIRM icon

SignatureFD’s Mirum Pharmaceuticals MIRM Stock Holding History

SignatureFD’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.5K Hold
170
– – ﹤0.01% 2560
2026
Q2 		$19.9K Hold
170
– – ﹤0.01% 2350
2026
Q1 		$15.7K Sell
170
-8
-4% -$753 ﹤0.01% 2314
2025
Q4 		$14.1K Sell
178
-12
-6% -$861 ﹤0.01% 2269
2025
Q3 		$13.9K Buy
190
+10
+6% +$636 ﹤0.01% 2273
2025
Q2 		$9.16K Sell
180
-35
-16% -$1.56K ﹤0.01% 2381
2025
Q1 		$9.7K Hold
215
– – ﹤0.01% 2371
2024
Q4 		$8.89K Sell
215
-6
-3% -$250 ﹤0.01% 2408
2024
Q3 		$8.62K Buy
221
+41
+23% +$1.64K ﹤0.01% 2386
2024
Q2 		$6.15K Buy
180
+10
+6% +$262 ﹤0.01% 2445
2024
Q1 		$4.27K Sell
170
-4
-2% -$110 ﹤0.01% 2586
2023
Q4 		$5.14K Buy
174
+4
+2% +$121 ﹤0.01% 2486
2023
Q3 		$5.37K Hold
170
– – ﹤0.01% 2463
2023
Q2 		$4.4K Sell
170
-5
-3% -$133 ﹤0.01% 2553
2023
Q1 		$4.2K Buy
175
+152
+661% +$3.46K ﹤0.01% 2577
2022
Q4 		$449 Buy
+23
New +$455 ﹤0.01% 3119

Other funds holding MIRM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Penn Capital Management
Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return

SignatureFD's MIRM Position: Q3 2026 in Review

SignatureFD held its Mirum Pharmaceuticals (MIRM) position steady in Q3 2026 at 170 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2560.

SignatureFD first reported a position in MIRM in Q4 2022 and has held it in 16 quarters since. The position peaked at $19.9K in Q2 2026. 123 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • SignatureFD held 170 shares of Mirum Pharmaceuticals worth $14.5K as of Q3 2026.
  • SignatureFD left its Mirum Pharmaceuticals share count unchanged in Q3 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2560 holding.
  • SignatureFD first reported a position in Mirum Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • SignatureFD's Mirum Pharmaceuticals position peaked at $19.9K in Q2 2026.
  • 123 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.